Answers are grounded in this paper and cite their sources.
Absence epilepsy is characterized by typical absence seizures with distinct electroclinical signatures. The main semiological feature is sudden behavioral arrest associated with brief impairment of consciousness, and the electroencephalographic (EEG) hallmark pattern is generalized, symmetric 2.5–4 Hz spike‐and‐wave discharges (GSW). Absence epilepsy diagnosis relies on correlating GSW with observable clinical manifestations. Monitoring therapeutic effects based solely on reported symptoms may be misleading, as behavioral arrest can be difficult to identify. Patients often do not recall most seizures, and observable motor/behavioral signs may be subtle, such as minimal twitches or transient lapses in responsiveness, which may go unnoticed. In clinical trials for absence epilepsies, quantification of GSW activity by EEG offers an objective and accurate measure of electrical burden and therapeutic efficacy. Despite technological limitations, GSW remains a robust neurophysiological endpoint. Increasing evidence indicates that the timing and burden of GSW correlate with epilepsy comorbidities, including attention, cognition, behavior, and sleep. We reviewed the published literature regarding GSW as an outcome measure in absence epilepsy, including nonseizure outcomes and comorbidities. Our review highlights (1) nearly 100% of clinical absence seizures exhibit sustained GSW discharges on EEG; (2) >49% of electrographic seizures are asymptomatic, indicating that reliance on seizure diaries without EEG monitoring underestimates seizure frequency and burden; (3) Genetic Generalized Epilepsy is not a benign condition and is associated with a high prevalence of cognitive and behavioral comorbidities, supporting evaluation beyond clinically observable seizures and the use of prolonged (≥24‐h) EEG monitoring; (4) circadian and multidien cycles further emphasize the need for prolonged EEG recordings to reduce timing‐related bias; and (5) antiseizure medications effective in absence epilepsy reduce GSW, supporting EEG monitoring as an objective treatment outcome measure. We therefore recommend incorporating ≥24‐h EEG in future clinical trials, especially in (young) adults, and exploring comorbidities as important outcome measures. Plain Language Summary Absence epilepsy causes brief episodes in which a person suddenly stops what they are doing and may not be aware of their surroundings. Many of these seizures have no obvious signs and are often missed or forgotten, meaning seizure diaries alone do not show the full picture. Our review shows that brain recordings (electroencephalographic, EEG), especially when done over 24 h or longer, detect many unrecognized seizures and better measure how well treatments work. EEG findings are also linked to problems with attention, thinking, behavior, and sleep, highlighting the need to look beyond visible seizures when evaluating treatments in clinical trials.
No takes yet. Share an insight, caveat, or question.
Sourbron et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: